Qinecsa CEO, Adam Sherlock, has been featured in Pharma Tech Outlook Europe’s latest issue, where he discusses how turning pharmacovigilance from a reactive function into a strategic advantage has become a competitive necessity.
With a singular focus on drug safety, Qinecsa combines advanced technologies with expert human insight to help manage complexity, ensure compliance, and drive better outcomes across every stage of the product lifecycle.
